Pfizer warns of a looming penicillin supply shortage

Pfizer is facing a shortage of penicillin due to increased demand and more diagnoses of syphilis.

Driving the news: In a letter to customers this week, Pfizer warned of an “impending stock out situation” for select Bicillin L-A and Bicillin C-R prefilled syringes, which are injectable penicillin.
* Prefilled Bicillin L-A pediatric syringes are expected to begin running low by the end of June, while all Bicillin C-R syringes could start diminishing in the third quarter of this year.
* Inventory is predicted to start recovering in the second and third quarters of 2024.

Wider context: The scarcity of penicillin comes amid a long-term shortage of prescription drugs the U.S. has been experiencing for the last decade, usually due to disruptions in the supply chain.
* Other prescriptions, such as Adderall and children’s flu medication, have also been affected by this shortage.

View original article on NPR

This summary was created by an AI system. The use of this summary is subject to our Terms of Service.

Contact us about this post






Leave a Reply

Your email address will not be published. Required fields are marked *